Skip to content
NewsBlazeAU – Lifestyle
Author:
Invivyd
Invivyd Announces REVOLUTION Program Progress and Advancement of Novel, Potential First- and Best-in-Class Measles Monoclonal Antibody Candidate VMS063 for Treatment and Prevention of Measles
April 9, 2026
Invivyd Launches “Antibodies for Any Body” in Partnership with World Champion Skier Lindsey Vonn to Inspire Actions that Help Support Immune Health
April 7, 2026
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 6, 2026
Invivyd Announces Presentation at the World Vaccine Congress Washington
March 30, 2026
←
Previous Page
1
2